ARL6IP5 and congenital rubella syndrome: By multivariable analysis, positive ARL6IP5 (weak, moderate, and strong), CRS and FIGO stage, were independent prognosticators for PFS (hazard ratio, 0.45; 95% CI, 0.21–0.95, Table 2); positive ARL6IP5, CRS, and serum CA 125 level were independent prognosticators for OS (hazard ratio, 0.24; 95% CI, 0.11–0.52).